Authors:
GROSSEHOVEST L
BRANDL M
DOHLSTEN M
KALLAND T
WILMANNS W
JUNG G
Citation: L. Grossehovest et al., TUMOR-GROWTH INHIBITION WITH BISPECIFIC ANTIBODY FRAGMENTS IN A SYNGENEIC MOUSE MELANOMA MODEL - THE ROLE OF TARGETED T-CELL CO-STIMULATIONVIACD28, International journal of cancer, 80(1), 1999, pp. 138-144
Authors:
NEWTON DW
DOHLSTEN M
LANDO PA
KALLAND T
OLSSON C
KOTB M
Citation: Dw. Newton et al., MHC CLASS II-INDEPENDENT, V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY SUPERANTIGEN MUTANTS FUSED TO ANTITUMOR F-AB FRAGMENTS - IMPLICATIONS FOR USE IN TREATMENT OF HUMAN COLON-CARCINOMA, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(1), 1998, pp. 157-162
Authors:
SRINIVAS U
DOHLSTEN M
KALLAND T
LUNDBLAD A
Citation: U. Srinivas et al., STAPHYLOCOCCAL ENTEROTOXIN-A-INDUCED IN-VITRO ADHESION OF HL-60 CELLSTO ENDOTHELIAL-CELLS INVOLVES BOTH SELECTIN AND INTEGRIN FAMILIES OF CELL-ADHESION MOLECULES, Scandinavian journal of immunology, 48(2), 1998, pp. 127-135
Authors:
ROSENDAHL A
KRISTENSSON K
HANSSON J
RIESBECK K
KALLAND T
DOHLSTEN M
Citation: A. Rosendahl et al., PERFORIN AND IFN-GAMMA ARE INVOLVED IN THE ANTITUMOR EFFECTS OF ANTIBODY-TARGETED SUPERANTIGENS, The Journal of immunology, 160(11), 1998, pp. 5309-5313
Authors:
ROSENDAHL A
KRISTENSSON K
HANSSON J
OHLSSON L
KALLAND T
DOHLSTEN M
Citation: A. Rosendahl et al., REPEATED TREATMENT WITH ANTIBODY-TARGETED SUPERANTIGENS STRONGLY INHIBITS TUMOR-GROWTH, International journal of cancer, 76(2), 1998, pp. 274-283
Authors:
GIANTONIO BJ
ALPAUGH RK
SCHULTZ J
MCALEER C
NEWTON DW
SHANNON B
GUEDEZ Y
KOTB M
VITEK L
PERSSON R
GUNNARSSON PO
KALLAND T
DOHLSTEN M
PERSSON B
WEINER LM
Citation: Bj. Giantonio et al., SUPERANTIGEN-BASED IMMUNOTHERAPY - A PHASE-I TRIAL OF PNU-214565, A MONOCLONAL-ANTIBODY STAPHYLOCOCCAL-ENTEROTOXIN A RECOMBINANT FUSION PROTEIN, IN ADVANCED PANCREATIC AND COLORECTAL-CANCER, Journal of clinical oncology, 15(5), 1997, pp. 1994-2007
Authors:
BELFRAGE H
DOHLSTEN M
HEDLUND G
KALLAND T
Citation: H. Belfrage et al., PREVENTION OF SUPERANTIGEN-INDUCED TOLERANCE IN-VIVO BY INTERLEUKIN-2TREATMENT, Cancer immunology and immunotherapy, 44(2), 1997, pp. 77-82
Authors:
PARRA E
VARGA M
HEDLUND G
KALLAND T
DOHLSTEN M
Citation: E. Parra et al., COSTIMULATION BY B7-1 AND LFA-3 TARGETS DISTINCT NUCLEAR FACTORS THATBIND TO THE INTERLEUKIN-2 PROMOTER - B7-1 NEGATIVELY REGULATES LFA-3-INDUCED NF-AT DNA-BINDING, Molecular and cellular biology, 17(3), 1997, pp. 1314-1323
Authors:
NEWTON D
DOHLSTEN M
LANDO P
KALLAND T
OLSSON C
KOTB M
Citation: D. Newton et al., MHC CLASS II-INDEPENDENT, V-BETA-SPECIFIC ACTIVATION OF T-CELLS BY SUPERANTIGEN MUTANTS FUSED TO ANTITUMOR ANTIBODIES - IMPLICATIONS FOR USE IN TREATMENT OF HUMAN COLON-CARCINOMA, Human immunology, 55, 1997, pp. 11-11
Authors:
LEHMANN D
KARUSSIS DM
FLURESCO D
MIZRACHIKOLL R
OVADIA H
SHEZEN E
KALLAND T
ABRAMSKY O
Citation: D. Lehmann et al., IMMUNOMODULATION OF AUTOIMMUNITY BY LINOMIDE - INHIBITION OF ANTIGEN PRESENTATION THROUGH DOWN-REGULATION OF MACROPHAGE ACTIVITY IN THE MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Journal of neuroimmunology, 74(1-2), 1997, pp. 102-110
Authors:
HANSSON J
OHLSSON L
PERSSON R
ANDERSSON G
ILBACK NG
LITTON MJ
KALLAND T
DOHLSTEN M
Citation: J. Hansson et al., GENETICALLY-ENGINEERED SUPERANTIGENS AS TOLERABLE ANTITUMOR AGENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2489-2494
Authors:
ANTONSSON P
WINGREN AG
HANSSON J
KALLAND T
VARGA M
DOHLSTEN M
Citation: P. Antonsson et al., FUNCTIONAL-CHARACTERIZATION OF THE INTERACTION BETWEEN THE SUPERANTIGEN STAPHYLOCOCCAL-ENTEROTOXIN-A AND THE TCR, The Journal of immunology, 158(9), 1997, pp. 4245-4251
Authors:
THIBODEAU J
DOHLSTEN M
CLOUTIER I
LAVOIE PM
BJORK P
MICHEL F
LEVEILLE C
MOURAD W
KALLAND T
SEKALY RP
Citation: J. Thibodeau et al., MOLECULAR CHARACTERIZATION AND ROLE IN T-CELL ACTIVATION OF STAPHYLOCOCCAL-ENTEROTOXIN A BINDING TO THE HLA-DR ALPHA-CHAIN, The Journal of immunology, 158(8), 1997, pp. 3698-3704
Authors:
SUNDSTEDT A
HOIDEN I
ROSENDAHL A
KALLAND T
VANROOIJEN N
DOHLSTEN M
Citation: A. Sundstedt et al., IMMUNOREGULATORY ROLE OF IL-10 DURING SUPERANTIGEN-INDUCED HYPORESPONSIVENESS IN-VIVO, The Journal of immunology, 158(1), 1997, pp. 180-186
Authors:
TORDSSON J
ABRAHMSEN L
KALLAND T
LJUNG C
INGVAR C
BRODIN T
Citation: J. Tordsson et al., EFFICIENT SELECTION OF SCFV ANTIBODY PHAGE BY ADSORPTION TO IN-SITU EXPRESSED ANTIGENS IN TISSUE-SECTIONS, Journal of immunological methods, 210(1), 1997, pp. 11-23
Authors:
ROSENDAHL A
HANSSON J
ANTONSSON P
SEKALY RP
KALLAND T
DOHLSTEN M
Citation: A. Rosendahl et al., A MUTATION OF F47 TO A IN STAPHYLOCOCCUS ENTEROTOXIN-A ACTIVATES THE T-CELL RECEPTOR V-BETA REPERTOIRE IN-VIVO, Infection and immunity, 65(12), 1997, pp. 5118-5124
Authors:
BELFRAGE H
DOHLSTEN M
HEDLUND G
KALLAND T
Citation: H. Belfrage et al., PREVENTION OF SUPERANTIGEN-INDUCED DOWN-REGULATION OF T-CELL MEDIATEDCYTOTOXIC ACTIVITY BY IL-2 IN-VIVO, Immunology, 90(2), 1997, pp. 183-188
Authors:
LABUDA T
PARRA E
HEDLUND G
KALLAND T
DOHLSTEN M
Citation: T. Labuda et al., THE TUMOR-ASSOCIATED CELL-SURFACE ANTIGEN A6H IS COSTIMULATORY FOR HUMAN CD4(-CELLS() BUT NOT CD8(+) T), Immunology, 90(2), 1997, pp. 236-243
Authors:
HOLZER U
ORLIKOWSKY T
ZEHRER C
BETHGE W
DOHLSTEN M
KALLAND T
NIETHAMMER D
DANNECKER GE
Citation: U. Holzer et al., T-CELL STIMULATION AND CYTOKINE RELEASE INDUCED BY STAPHYLOCOCCAL-ENTEROTOXIN-A (SEA) AND THE SEAD227A MUTANT, Immunology, 90(1), 1997, pp. 74-80
Authors:
GIDLOF C
DOHLSTEN M
LANDO P
KALLAND T
SUNDSTROM C
TOTTERMAN TH
Citation: C. Gidlof et al., A SUPERANTIGEN-ANTIBODY FUSION PROTEIN FOR T-CELL IMMUNOTHERAPY OF HUMAN B-LINEAGE MALIGNANCIES, Blood, 89(6), 1997, pp. 2089-2097